Ascentage Pharma Presents Data On Olverembatinib In CML-LBP And Ph+ BCP-ALL At ASCO 2026

(MENAFN - GlobeNewsWire - Nasdaq) ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, ...